 Connection
Max Seibold to Chemokine CCL5
This is a "connection" page, showing publications Max Seibold has written about Chemokine CCL5.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.218 |
|
|
|
-
Gauthier M, Kale SL, Oriss TB, Gorry M, Ramonell RP, Dalton K, Ray P, Fahy JV, Seibold MA, Castro M, Jarjour N, Gaston B, Bleecker ER, Meyers DA, Moore W, Hastie AT, Israel E, Levy BD, Mauger D, Erzurum S, Comhair SA, Wenzel SE, Ray A. CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma. J Allergy Clin Immunol. 2023 07; 152(1):94-106.e12.
Score: 0.218
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|